Growth Metrics

ClearPoint Neuro (CLPT) Free Cash Flow Growth (1y) (2012 - 2026)

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) FCF Growth (1y) (Qtr)
1 Abbott Laboratories 152.82 Bn 146.17 Bn 6.27 Bn -1.82%
2 Stryker 115.07 Bn 112.19 Bn 3.81 Bn 226.77%
3 Medtronic 95.25 Bn 87.08 Bn 5.76 Bn 9.73%
4 Boston Scientific 71.38 Bn 70.17 Bn 3.61 Bn -51.69%
5 Edwards Lifesciences 51.08 Bn 47.41 Bn 1.29 Bn -109.40%
6 Koninklijke Philips 29.38 Bn 26.07 Bn 2.07 Bn 133.09%
7 Dexcom 28.84 Bn 27.72 Bn 750.30 Mn 363.84%
8 GE HealthCare Technologies 28.56 Bn 26.49 Bn 1.98 Bn 108.16%
9 Steris 20.71 Bn 20.30 Bn 697.10 Mn 29.12%
10 ClearPoint Neuro 375.84 Mn 340.24 Mn 7.76 Mn -35.52%

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 -35.52%
Dec 31, 2025 -703.72%
Sep 30, 2025 -174.15%
Jun 30, 2025 0.94%
Mar 31, 2025 -65.49%
Dec 31, 2024 -26.55%
Sep 30, 2024 40.37%
Jun 30, 2024 50.57%
Mar 31, 2024 34.00%
Dec 31, 2023 61.66%
Sep 30, 2023 48.20%
Jun 30, 2023 -6.74%
Mar 31, 2023 -34.12%
Dec 31, 2022 13.54%
Sep 30, 2022 -14.62%
Jun 30, 2022 -37.31%
Mar 31, 2022 -99.82%
Dec 31, 2021 -49.52%
Sep 30, 2021 -150.26%
Jun 30, 2021 -115.63%
Mar 31, 2021 6.86%
Dec 31, 2020 -415.12%
Sep 30, 2020 -41.79%
Jun 30, 2020 -110.84%
Mar 31, 2020 -282.47%
Dec 31, 2019 20.08%
Sep 30, 2019 2.26%
Jun 30, 2019 29.13%
Mar 31, 2019 69.24%
Mar 31, 2016 39.90%
Dec 31, 2015 27.67%
Sep 30, 2015 23.54%
Jun 30, 2015 -69.20%
Mar 31, 2015 -106.07%
Dec 31, 2014 923.13%
Sep 30, 2014 -17.73%
Jun 30, 2014 22.78%
Mar 31, 2014 39.51%
Dec 31, 2013 33.00%
Sep 30, 2013 5.62%
Jun 30, 2013 -54.22%
Mar 31, 2013 -19.18%
Dec 31, 2012 -56.34%
Sep 30, 2012 -46.68%
Jun 30, 2012 24.20%
Mar 31, 2012 -20.41%